News Alert: NACHC Long-Time Leader Van Coverden Takes Leave, Could Augur Generational Change

NACHC informed health center stakeholders last night that its long-time leader Tom Van Coverden (left) has taken leave. NACHC Senior Vice President for Western Operations Rachel Gonzalez-Hanson has been appointed NACHC's interim president and CEO.

The National Association of Community Health Centers said in an email to its contacts yesterday that Tom Van Coverden, 74, hired by NACHC in 1975 and its leader for decades, has taken leave and been replaced by an interim president

Read More »

340B-Related Conference Organizers Readjust as COVID-19 Persists

The Marriott Marquis San Diego is the venue for both the 340B Coalition 2022 winter conference and the preceding 340B University educational program.

The 340B Coalition, citing the ongoing COVID-19 pandemic, decided Tuesday to give registrants for its upcoming Jan. 31 to Feb. 2 winter conference in San Diego, Calif., the option of attending in person or remotely via an online portal.

Apexus,

Read More »

340B “Anti-Pickpocketing” Bills Filed in Five States

The Florida Senate and four other state legislative chambers are considering bills 340B "anti-pickpocketing" legislation.

Bills have been filed in at least five state legislatures to protect 340B covered entities and their contract pharmacies from discrimination by pharmacy benefit managers (PBMs).

Sixteen states have enacted one or more such laws since 2019, according to

Read More »

In Big Win for Pharmacy Groups, CMS Proposes Significant Changes to Medicare Part D Clawbacks

CMS wants to change Medicare Part D rules to rein in PBMs' controversial practice of clawing back drug payments to pharmacies after point of sale.

The Centers for Medicare & Medicaid Services (CMS) yesterday proposed changing Medicare Part D rules to curb plan sponsors and pharmacy benefit managers’ skyrocketing use of direct and indirect renumeration fees (DIR)—PBMs’ controversial practice of clawing back drug payments to

Read More »
Industry Insights Logo

Visante’s Top 10 Issues Facing Hospital & Health System Pharmacy in 2022

SPONSORED CONTENT

Each year, Visante publishes its list of the top 10 issues facing hospital and health system pharmacy. In 2022, many challenges derive from the pandemic but also present opportunities for leaders to implement new solutions that will drive stronger performance in the future.

  1. The Pandemic

With a second

Read More »

PhRMA Says More than Half of Pharmacy and Provider Profits on Brand Drug Sales Come Through 340B

New research looked at the prices 340B-enrolled pediatric hospitals charged for pediatric oncology drugs.

More than half (52%) of the $81 billion that U.S. pharmacies and health care providers collected in 2020 in reimbursement from payers for brand-name prescription drugs came through pharmacy and provider participation in the 340B program, up from 14% of

Read More »

In a Big Relief for 340B Providers, Sen. Thune Will Run Again

U.S. Sen. John Thune (S.D.), a staunch 340B provider ally and the Senate’s No. 2 Republican, announced over the weekend he will seek re-election in November.

340B providers are sighing relief after U.S. Sen. John Thune (S.D.), a staunch 340B provider ally and the Senate’s No. 2 Republican, announced over the weekend he will seek re-election in November.

Thune announced that he was running on

Read More »

N.Y. State and Va. Health Centers Ask Fed. Judge to Let their 340B-Related Antitrust Suit Against Drug Makers Go on

New York state health center Mosaic Health and its co-plaintiff Central Virginia Health Services are opposing four insulin and diabetes drug manufacturers’ motion to dismiss their antitrust class action over the companies’ denials of 340B pricing when covered entities use contract pharmacies.

New York state and Virginia health centers on Friday asked a federal district judge to deny four insulin and diabetes drug manufacturers’ motion to dismiss the health centers’ antitrust class action over the companies’ denials of 340B pricing when covered

Read More »

Judge Denies Calif. 340B Health Centers’ Motion to Halt State Medicaid Drug Payment Change

California health centers say they will continue to fight against the transfer of state Medicaid managed care drug coverage to Medicaid fee for service, despite being denied a temporary restraining order against the change.

A federal judge in Sacramento, Calif., late yesterday declined to stop California Medicaid’s transfer of managed care drug coverage to Medicaid fee for service that took effect on Jan. 1. Health centers enrolled in the 340B drug pricing program pledged

Read More »

340B PROVIDER LEADER SPOTLIGHT

Marcus Cox, Chief Pharmacy Officer, Klamath Health Partnership, Inc

Marcus Cox

Q: Where did you go to college/graduate school?

I graduated Pharmacy school from Oregon State University in 1999. I first graduated with a BS in Chemistry from Southern Oregon

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live